首页> Journal of acquired immune deficiency syndromes (1999)> Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody.

Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody.

导出 OA

翻译打印收藏纠错

第一作者： Srilatha,Edupuganti

第一单位： Division of Infectious Disease, Department of Medicine, Emory University, Atlanta, GA.

作者： Srilatha,Edupuganti ^[1] ; Nyaradzo,Mgodi ^[2] ; Shelly T,Karuna ^[3] ; Philip,Andrew ^[4] ; Erika,Rudnicki ^[3] ; Nidhi,Kochar ^[3] ; Allan,deCamp ^[3] ; Robert,De La Grecca ^[3] ; Maija,Anderson ^[3] ; Carissa,Karg ^[3] ; India,Tindale ^[3] ; Elizabeth,Greene ^[4] ; Gail B,Broder ^[3] ; Jonathan,Lucas ^[4] ; John,Hural ^[3] ; Jorge A,Gallardo-Cartagena ^[5] ; Pedro,Gonzales ^[6] ; Ian,Frank ^[7] ; Magdalena,Sobieszczyk ^[8] ; Margarita M,Gomez Lorenzo ^[9] ; David,Burns ^[9] ; Peter L,Anderson ^[10] ; Maurine D,Miner ^[3] ; Julie,Ledgerwood ^[11] ; John R,Mascola ^[11] ; Peter B,Gilbert ^[12] ; Myron S,Cohen ^[4] ; Lawrence,Corey ^[3] ; HVTN 704/HPTN 085 study group

作者单位： Division of Infectious Disease, Department of Medicine, Emory University, Atlanta, GA. ^[1] University of Zimbabwe College of Health Sciences Clinical Trials Research Centre, Harare, Zimbabwe. ^[2] Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA. ^[3] Institute for Global Health and Infectious Disease, University of North Carolina, Chapel Hill, NC. ^[4] Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales, Universidad Nacional Mayor de San Marcos, Lima, Peru. ^[5] Servicio de Enfermedades Infecciosas y Tropicales, Hospital Nacional Dos de Mayo, Lima. ^[6] Department of Medicine, Division of Infectious Diseases, University of Pennsylvania, Pennsylvania, PA. ^[7] Department of Medicine, Division of Infectious Diseases, Columbia University, New York, NY. ^[8] Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD. ^[9] Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO. ^[10] Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; and. ^[11] Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.;Department of Biostatistics, Univeristy of Washington, Seattle, WA. ^[12]